内射交换多P国产,少妇高清精品毛片在线视频 ,亚洲av无码国产综合专区,欧美性xxxxx极品少妇,永久免费AV无码网站国产,国产色视频一区二区三区qq号,欧美喷潮最猛视频,中文精品无码中文字幕无码专区

20251015-173344.jpg 20251015-174951.jpg

Innovation of Radiopharmaceuticals to address unmet clinical needs

Pipelines
首頁廠房背景圖.png 首頁移動(dòng)端banner 拷貝.png

From Biotech to Biopharma

Pipelines
20250616-105002.jpg home2.jpg

From Biotech to Biopharma

Pipelines

NORROY is a R&D-oriented biotech

focused on the development and commercialization of radiopharmaceutical theranostics and automated synthesizer & functional modules for radiopharmaceutical production in both R&D and GMP settings.

Founded in July 2021, NORROY has developed more than 7 pipelines currently under clinical investigations in solid tumors, include urological cancers, gastrointestinal & pancreatic cancers, lung cancers, breast & ovarian cancers, nasopharyngeal cancers, etc. In addition to innovation of radiopharmaceuticals pipelines and automated modules, NORROY also continues to establish a solid global supply of multiple radioisotopes, build commercial GMP manufacturing facilities and global distribution network with international partners.

Up to date, NORROY has received 5 IND clearance from the U.S. Food and Drug Administration (FDA), and 5 IND approvals from the National Medical Products Administration (NMPA). Recently, NORRY works closely with the regulatory agencies to advance its late-stage portfolios through internationally registered clinical trial investigations.
Meet our Company

What makes
NORROY different?

Learn More
  • 600 +

    Patients Studied


  • 5

    IND Approvals by
    U.S. FDA

  • 5

    IND Approvals by
    China NMPA


  • 2

    Pipelines Completed
    Phase Ⅱ Studies

  • 12 +

    Pipelines in
    Clinical Stage

  • 30 +

    Publications of
    Our Pipelines